Navigation Links
Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP
Date:11/21/2007

SOUTH SAN FRANCISCO, Calif., Nov. 21 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will host a conference call with simultaneous webcast to discuss the results of its Phase 2 clinical study of R788, a novel, oral Syk kinase inhibitor, in patients with Immune Thrombocytopenic Purpura (ITP) on Tuesday, December 4, 2007 at 4:30pm E.S.T. Participating on the call will be Rigel senior management and the principal investigator on the study, James B. Bussel, M.D., director of the Platelet Research and Treatment program at the Phyllis and David Komansky Center for Children's Health and NewYork-Presbyterian Hospital/Weill Cornell Medical Center and professor of pediatrics in obstetrics and gynecology and in medicine at the Weill Cornell Medical College. In addition, Rigel will be presenting a poster on R788 in ITP at the ASH meeting on December 8, 2007, from 9:00a.m. - 7:30p.m., in Atlanta, GA.

Conference Call Details

To access the live call, please dial 866-831-6267 (domestic) or 617-213-8857 (international) 10 minutes prior to the start time and use the passcode 14390209. A replay of the call will be available at approximately 3:30p.m. PST on December 4, 2007 until December 11, 2007. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and use the passcode 91472601.

The conference call will also be webcast live and can be accessed from Rigel's website at http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary. A replay of the conference call will b
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Rigel Announces Third Quarter 2007 Financial Results
2. Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study
3. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
5. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
6. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
9. AtriCure to Present at Roth Capital Partners 2007 New York Conference
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. MDS to Present at Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...mental and physical health , , MONDAY, N...ake as many years off your life as smoking does, a...f depression and anxiety appears to be better for ...ame to their conclusions after analyzing death rec...ng the four years after the survey, the death rate...
(Date:11/23/2009)... brain is regulated by a peptide known as C3a, whi...o nerve cells and is also important for the migrat...eveals new research from the Sahlgrenska Academy p... the research has been carried out using mice and ...r human beings, which could be given to patients w...
(Date:11/23/2009)...used Strategic Communications Agency Honored by As...nals , Salem, MA (PRWEB) ...focused strategic communications agency, announced...ward in the design/website homepage category admin... and Communication Professionals. The MarCom 2009 ...
(Date:11/23/2009)...e/--XiotechCorporationtodayannouncedthatMasonGener...agesystem,poweredbyIntelligentStorageElement(ISE(T...enablefuturegrowthanddeliversignificantcapitalando..., MasonGeneral,locatedinShelton,Wash.,wasratedoneo...d-Rural"hospitalsin2008and2009foritssuperioruseofi...
(Date:11/23/2009)...tandably captured the attention of public health o...alysis from Children,s Hospital Boston, based on p...ng several recent flu seasons, shows that another ...a substantially greater disease toll among young c...ata come from the pre-H1N1 influenza era, the anal...
Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3
...etic variations strongly associated with familial ...at Washington University School of Medicine in St.... and the United Kingdom. , The researchers found a...ot affected by whether the study participants smok...
...s in the United States undergo lung surgery each y...lity of their care. In the current issue of The A...ave proposed a system of lung surgery quality indi... are frequently reported. However, because they ar...
...y hospitals still giving them to new moms , ... to a new study, the majority of East Coast hospit..., even though most major medical organizations opp... in 21 Eastern states and the District of Columbia...
...ows promising results in the treatment of a this c... (Vocus) September 9, 2008 -- A pilot animal...nshospital.org/az/Site1062/mainpageS1062P0.html [...f the defect while in utero, may help repair spina...
...CH, Fla., Sept. 9 Celsius Holdings,Inc. (OTC Bull...ition to,its board of directors. Mr. Geary Cotton ...rsons that Mr. Carl DeSantis has the right to name...own,a consumer products company, where he worked u...
...s good foods taste better, helps breads rise, crea... the safety of jams and jellies. But,did you know ... jellies can,also help heal wounds?, Sugar is one...ing powers. Sugar has been used to treat wounds ac...
Other Medicine News:Health News:Genetic region linked to a 5 times higher lung cancer risk 2Health News:Genetic region linked to a 5 times higher lung cancer risk 3Health News:Mayo Clinic chest surgeons propose measures for indicating quality of lung surgery 2Health News:Mayo Clinic chest surgeons propose measures for indicating quality of lung surgery 3Health News:Formula Samples Hinder Breast-Feeding Efforts 2Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 2Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 3Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 4Health News:Celsius Strengthens Board With Prior Rexall Sundown CFO 2Health News:Sugar's Healing Powers 2
(Date:11/23/2009)..., EXTON,Pa.,Nov.23/PRNewswire/--BioTrendsResearch... Feraheme report,thesecondinamulti-phasesyndicate...IVironproduct,Feraheme,throughthefirstsixmonthsofp...titativeinformationfrom50uniqueNephrologistsandqua...strialanduseofFeraheme,obstaclestouse,reasonstouse...
(Date:11/23/2009)..., WALTHAM,Mass.,Nov.23/PRNewswire/--ProteonTherap...yofitsleadproduct,PRT-201,inend-stagerenaldisease(...t(AVG)creation.TheAVGstudyrepresentsProteon,ssecon...lyannouncingtheinitiationofaPhase1/2studyofPRT-201...tula(AVF)creationearlierthisyear.Proteonalsoannoun...
(Date:11/23/2009)..., SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswire-Firs...hatDr.TedW.LoveandDr.DavidC.U,Prichardhaveagreedto...ftheproposedmergerbetweenAnesivaandArcionTherapeut...tescheduledtotakeplaceatthepreviouslyannouncedAnes...ber3,2009at9:00a.m.PSTat400OysterPoint,Suite107A,S...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 1Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 2Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 3AMICAS Showcases Vendor Neutral Archive Solutions at SIIM 2009 47969 1AMICAS Showcases Vendor Neutral Archive Solutions at SIIM 2009 47969 2AMICAS Showcases Vendor Neutral Archive Solutions at SIIM 2009 47969 3AMICAS Showcases Vendor Neutral Archive Solutions at SIIM 2009 47969 4Once Monthly Dosing 3A How Much of a Competitive Advantage is it 3F Rheumatologists Provide Insight in the Baseline Report of LaunchTrends 28TM 29 3A 47967 1Once Monthly Dosing 3A How Much of a Competitive Advantage is it 3F Rheumatologists Provide Insight in the Baseline Report of LaunchTrends 28TM 29 3A 47967 2
SCANLISA Anti-PR3 IgG
...gy relates to the ultrasensitive measurement of Ad... cells. ATP produced by the AK reaction is measur...ogy to microbiological identification techniques, ...eads, Acolyte can measure bacteria and yeasts fast...
...a differential medium designed for the direct dete...s are incorporated for the suppression of gram-neg...d yeast. S. aureus hydrolyzes the chromogenic subs... differentiation from other gram-positive organism...
...diagnostic test cleared by the FDA and by Health C...on by methicillin resistant Staphylococcus aureus ...-MRSA test results are available in about one hour... other methods that require two to five days. By d...
Medicine Products: